GLAUPREXA Trademark

Trademark Overview

On Thursday, December 12, 2013, a trademark application was filed for GLAUPREXA with the United States Patent and Trademark Office. The USPTO has given the GLAUPREXA trademark a serial number of 86141852. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 12, 2017. This trademark is owned by Allergan, Inc.. The GLAUPREXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of glaucoma
glauprexa

General Information

Serial Number86141852
Word MarkGLAUPREXA
Filing DateThursday, December 12, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 12, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of glaucoma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 26, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Monday, June 12, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 12, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 19, 2016EXTENSION 5 GRANTED
Friday, September 16, 2016EXTENSION 5 FILED
Friday, September 16, 2016TEAS EXTENSION RECEIVED
Wednesday, March 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 15, 2016EXTENSION 4 GRANTED
Thursday, February 25, 2016EXTENSION 4 FILED
Thursday, February 25, 2016TEAS EXTENSION RECEIVED
Tuesday, September 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 21, 2015EXTENSION 3 GRANTED
Wednesday, September 16, 2015EXTENSION 3 FILED
Wednesday, September 16, 2015TEAS EXTENSION RECEIVED
Saturday, April 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 10, 2015EXTENSION 2 GRANTED
Tuesday, March 3, 2015EXTENSION 2 FILED
Wednesday, April 8, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 3, 2015TEAS EXTENSION RECEIVED
Saturday, September 6, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 4, 2014EXTENSION 1 GRANTED
Thursday, September 4, 2014EXTENSION 1 FILED
Thursday, September 4, 2014TEAS EXTENSION RECEIVED
Tuesday, May 6, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 30, 2014ASSIGNED TO EXAMINER
Thursday, December 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 16, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

glauprexa glaucoma treatment preparations pharmaceutical